Iclusig 30MG tab

Ended Awarded

Contract number
36C26025F0421
Awardee
Awarding agency
Obligated
$14,434

Award facts

Contract value 100% obligated
$14,434.08 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Wildwood, MO 63005, USA

Award details come from SAM.gov/FPDS.

About this award

This federal contract award is for the delivery of ICLUSIG 30MG TAB pharmaceutical products to the U.S. Department of Veterans Affairs (VA). The $14,434.08 firm-fixed-price delivery order was awarded to Takeda Pharmaceuticals America, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, under the company's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs. The contract supports the VA's mission of providing comprehensive healthcare services to veterans by ensuring efficient access to critical oncology medications. This delivery order does not utilize any small business set-aside designations. The contract has an ultimate completion date of October 5, 2025 and is part of a larger $123.5 million Blanket Purchase Agreement (BPA) between Takeda Pharmaceuticals America, Inc. and the VA National Acquisition Center, which is designed to streamline the procurement of ICLUSIG (ponatinib) to VA medical facilities nationwide.

Quick answers

Who was awarded contract 36C26025F0421?

36C26025F0421 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on September 25, 2025.

How much is contract 36C26025F0421 worth?

The government has obligated $14,434 on 36C26025F0421.

Is contract 36C26025F0421 an order under another contract?

Yes. 36C26025F0421 is a delivery order under 36F79725D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26025F0421 competed?

The extent of competition for 36C26025F0421 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award